Evaluation of RIX4414, a live, attenuated rotavirus vaccine, in a randomized, double-blind, placebo-controlled phase 2 trial involving 2464 Singaporean infants

• Main Authors: Phua, K.B., Quak, S.H., Lee, B.W., Emmanuel, S.C., Goh, P., Han, H.H., Bock, H.L., De, Vos B.
• Other Authors: PAEDIATRICS
• Format: Conference or Workshop Item
• Published: 2011
• Online Access: http://scholarbank.nus.edu.sg/handle/10635/25710
• Institution: National University of Singapore

10.1086/431511